Cite Filings / RYTM / 0000102909-25-000210

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

RHYTHM PHARMACEUTICALS, INC. Filed 2025-10-30 Acc 0000102909-25-000210

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-11-03 4 Chief Technical Officer sold 9,748 shares at $115.24 ($1,123,398)
2025-10-30 144 Sale of Securities
2025-10-30 4 Chief Technical Officer sold 2,815 shares at $115.01 ($323,750)
2025-10-30 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-10-28 144 Sale of Securities
2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…